|0.025|| +0.0006 / +2.46%|
PositiveID Corp. develops molecular diagnostic systems for bio-threat detection and rapid medical testing. The company, through its subsidiary, MicroFluidic Systems, develops fully automated pathogen detection systems and assays to detect a range of biological threats. It focuses on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment. PositiveID was founded in November 2001 and is headquartered in Delray Beach, FL.
|William J. Caragol||Chairman, Chief Executive Officer, CFO & Treasurer|
|Lyle L. Probst||President|
|Allison F. Tomek||SVP-Investor Relations & Corporate Communications|